Publication | Closed Access
Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway
32
Citations
20
References
2022
Year
Oncogenic AgentMedicinePharmacologyCancer GrowthColorectal CancerMitochondrial PathwayTumor SuppressorOncologyCell BiologyTumor MicroenvironmentTumor BiologyOncogenic Activity
| Year | Citations | |
|---|---|---|
Page 1
Page 1